Skip to main content
Top
Published in: Rheumatology International 10/2010

01-08-2010 | Original Article

Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors?

Authors: Veli Yazisiz, Gokhan Arslan, İrem Hicran Ozbudak, Sema Turker, Funda Erbasan, Ali Berkant Avci, Omer Ozbudak, Ender Terzioglu

Published in: Rheumatology International | Issue 10/2010

Login to get access

Abstract

The aim of this study was to investigate the prevalence, predictors and radiological findings of primary Sjögren’s syndrome (pSS)-associated lung involvement. This retrospective cohort study included 123 patients with demographic, clinical, laboratory and radiological data who were diagnosed with pSS. Lung involvement was defined based on the presence of pulmonary signs/symptoms and/or impaired pulmonary function tests along with alterations in high-resolution computerized tomography (HRCT). Thirty patients (24.4%) had pulmonary signs/symptoms at the initial presentation and/or during the follow-up period. Based on the criteria, 14 patients (11.4%) were defined as having pSS with lung involvement. The smoking rate, male/female ratio and the mean ages were found to be higher in patients with lung involvement (P < 0.05). Positive IgM-rheumatoid factor (RF), anti-La and anti-Ro results, the presence of hypergammaglobulinemia and lymphopenia had high specificity despite the low sensitivity rates to detect pSS-associated lung disease. A significant difference was found in forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) results between the patients with and without lung involvement. Impaired FEV1 had high specificity and positive predictive value compared to impaired FVC, particularly in non-smoker patients. The most frequent HRCT finding was ground-glass attenuation (64.3%). Other common findings were bronchiectasis, reticular pattern and honeycombing. The lesions involved predominantly the lower lobes. In conclusion, the presence of hypergammaglobulinemia and lymphopenia, positivity for RF, anti-La and anti-Ro, and impaired (FVC) and/or FEV1 values could be the predictive parameters with a high specificity despite the low sensitivity rates. Smoking history, male gender and age are also risk factors. These parameters may be helpful to distinguish pSS-associated lung involvement from lung disorders unrelated to pSS.
Literature
2.
go back to reference Gardiner P, Ward C, Allison A et al (1993) Pleuropulmonary abnormalities in primary Sjogren’s syndrome. J Rheumatol 20:831–837PubMed Gardiner P, Ward C, Allison A et al (1993) Pleuropulmonary abnormalities in primary Sjogren’s syndrome. J Rheumatol 20:831–837PubMed
3.
go back to reference Deheinzelin D, Capelozzi VL, Kairalla RA et al (1996) Interstitial lung disease in primary Sjogren’s syndrome. Clinical–pathological evaluation and response to treatment. Am J Respir Crit Care Med 154:794–799PubMed Deheinzelin D, Capelozzi VL, Kairalla RA et al (1996) Interstitial lung disease in primary Sjogren’s syndrome. Clinical–pathological evaluation and response to treatment. Am J Respir Crit Care Med 154:794–799PubMed
4.
go back to reference Davidson BK, Kelly CA, Griffiths ID (2000) Ten-year follow-up of pulmonary function in patients with primary Sjogren’s syndrome. Ann Rheum Dis 59:709–712CrossRefPubMed Davidson BK, Kelly CA, Griffiths ID (2000) Ten-year follow-up of pulmonary function in patients with primary Sjogren’s syndrome. Ann Rheum Dis 59:709–712CrossRefPubMed
5.
go back to reference Cain HC, Noble PW, Matthay RA (1998) Pulmonary manifestations of Sjogren’s syndrome. Clin Chest Med 19:687–699CrossRefPubMed Cain HC, Noble PW, Matthay RA (1998) Pulmonary manifestations of Sjogren’s syndrome. Clin Chest Med 19:687–699CrossRefPubMed
6.
go back to reference Ito I, Nagai S, Kitaichi M et al (2005) Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171:632–638CrossRefPubMed Ito I, Nagai S, Kitaichi M et al (2005) Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171:632–638CrossRefPubMed
7.
go back to reference Yamadori I, Fujita J, Bandoh S et al (2002) Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjogren’s syndrome. Rheumatol Int 22:89–92CrossRefPubMed Yamadori I, Fujita J, Bandoh S et al (2002) Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjogren’s syndrome. Rheumatol Int 22:89–92CrossRefPubMed
8.
go back to reference Travis WD, Colby TV, Koss MN (2002) Non-neoplastic disorders of the lower respiratory tract. Armed Forces Institute of Pathology, Washington, DC Travis WD, Colby TV, Koss MN (2002) Non-neoplastic disorders of the lower respiratory tract. Armed Forces Institute of Pathology, Washington, DC
9.
go back to reference Yazisiz V, Avci AB, Erbasan F et al (2009) Diagnostic performance of minor salivary gland biopsy, serological and clinical data in Sjogren’s syndrome: a retrospective analysis. Rheumatol Int 29:403–409CrossRefPubMed Yazisiz V, Avci AB, Erbasan F et al (2009) Diagnostic performance of minor salivary gland biopsy, serological and clinical data in Sjogren’s syndrome: a retrospective analysis. Rheumatol Int 29:403–409CrossRefPubMed
10.
go back to reference Theander E, Manthorpe R, Jacobsson LT (2004) Mortality and causes of death in primary Sjogren’s syndrome: a prospective cohort study. Arthritis Rheum 50:1262–1269CrossRefPubMed Theander E, Manthorpe R, Jacobsson LT (2004) Mortality and causes of death in primary Sjogren’s syndrome: a prospective cohort study. Arthritis Rheum 50:1262–1269CrossRefPubMed
11.
go back to reference Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMed Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMed
12.
go back to reference American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277–304 American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias (2002) This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165:277–304
13.
go back to reference Taouli B, Brauner MW, Mourey I et al (2002) Thin-section chest CT findings of primary Sjogren’s syndrome: correlation with pulmonary function. Eur Radiol 12:1504–1511CrossRefPubMed Taouli B, Brauner MW, Mourey I et al (2002) Thin-section chest CT findings of primary Sjogren’s syndrome: correlation with pulmonary function. Eur Radiol 12:1504–1511CrossRefPubMed
14.
go back to reference Ramos-Casals M, Solans R, Rosas J et al (2008) Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 87:210–219CrossRef Ramos-Casals M, Solans R, Rosas J et al (2008) Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore) 87:210–219CrossRef
15.
go back to reference Saag KG, Kolluri S, Koehnke RK et al (1996) Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 39:1711–1719CrossRefPubMed Saag KG, Kolluri S, Koehnke RK et al (1996) Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 39:1711–1719CrossRefPubMed
16.
go back to reference Shadick NA, Fanta CH, Weinblatt ME et al (1994) Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore) 73:161–170CrossRef Shadick NA, Fanta CH, Weinblatt ME et al (1994) Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore) 73:161–170CrossRef
17.
go back to reference Anaya JM, Diethelm L, Ortiz LA et al (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24:242–254CrossRefPubMed Anaya JM, Diethelm L, Ortiz LA et al (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24:242–254CrossRefPubMed
18.
go back to reference Mori S, Cho I, Koga Y et al (2008) Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513–1521PubMed Mori S, Cho I, Koga Y et al (2008) Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 35:1513–1521PubMed
19.
go back to reference Garcia-Carrasco M, Siso A, Ramos-Casals M et al (2002) Raynaud’s phenomenon in primary Sjogren’s syndrome. Prevalence and clinical characteristics in a series of 320 patients. J Rheumatol 29:726–730PubMed Garcia-Carrasco M, Siso A, Ramos-Casals M et al (2002) Raynaud’s phenomenon in primary Sjogren’s syndrome. Prevalence and clinical characteristics in a series of 320 patients. J Rheumatol 29:726–730PubMed
20.
go back to reference Alexander EL, Arnett FC, Provost TT et al (1983) Sjogren’s syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 98:155–159PubMed Alexander EL, Arnett FC, Provost TT et al (1983) Sjogren’s syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 98:155–159PubMed
21.
go back to reference Moutsopoulos HM, Zerva LV (1990) Anti-Ro (SSA)/La (SSB) antibodies and Sjogren’s syndrome. Clin Rheumatol 9:123–130CrossRefPubMed Moutsopoulos HM, Zerva LV (1990) Anti-Ro (SSA)/La (SSB) antibodies and Sjogren’s syndrome. Clin Rheumatol 9:123–130CrossRefPubMed
22.
go back to reference Franquet T, Gimenez A, Monill JM et al (1997) Primary Sjogren’s syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 169:655–658PubMed Franquet T, Gimenez A, Monill JM et al (1997) Primary Sjogren’s syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 169:655–658PubMed
23.
go back to reference Tanaka N, Kim JS, Newell JD et al (2004) Rheumatoid arthritis-related lung diseases: CT findings. Radiology 232:81–91CrossRefPubMed Tanaka N, Kim JS, Newell JD et al (2004) Rheumatoid arthritis-related lung diseases: CT findings. Radiology 232:81–91CrossRefPubMed
24.
go back to reference Galie N, Manes A, Farahani KV et al (2005) Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 14:713–717CrossRefPubMed Galie N, Manes A, Farahani KV et al (2005) Pulmonary arterial hypertension associated to connective tissue diseases. Lupus 14:713–717CrossRefPubMed
25.
go back to reference Launay D, Hachulla E, Hatron PY et al (2007) Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 86:299–315CrossRef Launay D, Hachulla E, Hatron PY et al (2007) Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 86:299–315CrossRef
26.
go back to reference Bertoni M, Niccoli L, Porciello G et al (2005) Pulmonary hypertension in primary Sjogren’s syndrome: report of a case and review of the literature. Clin Rheumatol 24:431–434CrossRefPubMed Bertoni M, Niccoli L, Porciello G et al (2005) Pulmonary hypertension in primary Sjogren’s syndrome: report of a case and review of the literature. Clin Rheumatol 24:431–434CrossRefPubMed
27.
go back to reference Vassiliou VA, Moyssakis I, Boki KA et al (2008) Is the heart affected in primary Sjogren’s syndrome? An echocardiographic study. Clin Exp Rheumatol 26:109–112PubMed Vassiliou VA, Moyssakis I, Boki KA et al (2008) Is the heart affected in primary Sjogren’s syndrome? An echocardiographic study. Clin Exp Rheumatol 26:109–112PubMed
28.
go back to reference Turesson C, Jacobsson L, Bergstrom U (1999) Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 38:668–674CrossRef Turesson C, Jacobsson L, Bergstrom U (1999) Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 38:668–674CrossRef
Metadata
Title
Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors?
Authors
Veli Yazisiz
Gokhan Arslan
İrem Hicran Ozbudak
Sema Turker
Funda Erbasan
Ali Berkant Avci
Omer Ozbudak
Ender Terzioglu
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1152-8

Other articles of this Issue 10/2010

Rheumatology International 10/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.